Landmark Ideas Series: Envisioning Clinical Evidence Generation of the Future (Video Available)

Speaker: Amy Abernethy, MD, PhD; Former Principal Deputy Commissioner and acting Chief Information Officer of Food and Drugs of the US Food and Drug Administration (FDA), at Verily

Date: January 20, 2022 at 4:00PM - 5:30PM

Clinical research is undergoing a major shift, as regulators and sponsors move towards continuous evidence generation to study how interventions perform over time. In this talk, we’ll explore what’s accelerating this trend, how new tools and technologies are advancing the space, and how it can ultimately enable more personalized care.

Dr. Abernethy oversees the overall product vision and related clinical research portfolio at Verily. Dr. Abernethy was most recently Principal Deputy Commissioner of Food and Drugs of the US Food and Drug Administration (FDA) and the agency's acting Chief Information Officer. In just over two years with FDA, Dr. Abernethy is credited with having catalyzed enduring changes in the way the FDA uses data as well as advancing FDA's work in RWE and personalized medicine. She also spearheaded FDA's shift toward cloud-based data interoperability, thereby streamlining the agency's interaction with the health data ecosystem as outlined in the agency's technology and data modernization action plans.


Publications

Sathyanarayana A, El Atrache R, Jackson M, Cantley S, Reece L, Ufongene C, Loddenkemper T, Mandl KD, Bosl WJ. Measuring Real-Time Medication Effects From Electroencephalography. Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society 2022.

Weitzman ER, Kossowsky J, Blakemore LM, Cox R, Dowling DJ, Levy O, Needles EW, Levy S. Acceptability of a Fentanyl Vaccine to Prevent Opioid Overdose and Need for Personalized Decision-Making. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2022.

Weitzman ER, Sherman AC, Levy O. Pediatric SARS-CoV-2 Vaccines: Perceptions and Attitudes from the FDA Public Commentary. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2022.